| Metric | შპს ნიუ ფარმა | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾14.6m₾21.9m | ₾2.36bn₾2.11bn |
| Revenue growth | -33.2% | 11.8% |
| Profitability | ||
| EBITDA | -₾27k₾3.5m | — |
| EBITDA margin | -0.2%15.8% | — |
| Net profit | -₾1.2m₾2.1m | ₾1.24bn₾1.12bn |
| Net margin | -8.4%9.7% | 52.8%53.0% |
| Balance sheet | ||
| Total assets | ₾9.7m₾10.9m | ₾37.66bn₾31.77bn |
| Total equity | ₾3.4m₾5.9m | ₾5.45bn₾4.75bn |
| ROE | -35.4%36.1% | 22.8%23.6% |